LD-2 disclosure · 3rd Quarter - Report
HCA
Client
- Name
- HCA
- Location
- Tennessee · United States of America
Registrant
- Description
- Government relations and business consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
S 2840 Bipartisan Primary Care and Health Workforce Act (all sections of full text) HR 4822 Health Care Price Transparency Act of 2023 (all sections of full text) S 468 Hospital Transparency Compliance Enforcement Act (all sections of full text) Discussions involving the extension of ACA subsidies Discussions involving 340B Drug Pricing Program Discussions involving Medicare sequestration Discussions involving CMS rulemaking Monitored S 1636 Protecting Rural Telehealth Access Act Monitored HR 3440 Protecting Rural Telehealth Access Act Monitored S 2016 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023 Monitored HR 4189 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023 Monitored discussions related to cyber-security threats on healthcare industry providers Monitored discussions pertaining to CMS rulemaking on surprise billing ban Monitored discussions pertinent to health care group purchasing organizations (GPOs) Monitored nominations to executive branch agencies and federally authorized commissions Monitored CMS price transparency rule for hospitals
LobbyistsJAMES C FREE · ROBERT HICKMOTT · mr JACK S DEUSER jr · TREVOR W. KOLEGO · W. TIMOTHY LOCKE · MICHAEL A. GAFFIN · SARAH DUMONT MERCHAK · mr JOHN CHRISTIE iii
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Medicare/Medicaid
Discussions pertaining to CMS hospital directed payment program Discussions pertaining to reductions to the Medicaid disproportionate share hospital (DSH) program S 470 Patient Access to Higher Quality Health Care Act of 2023 (all sections of full text)(oppose) HR 977 Patient Access to Higher Quality Health Care Act of 2023 (all sections fo full text) (oppose) S 1869 Site-based Invoicing and Transparency Enhancement (SITE) Act (all sections of full text) Discussions relating to site neutral payment reform Discussions pertaining to prior authorization Monitored Medicare Advantage reform legislation on CMS action
